Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.03%64.25B | 4.00%16.09B | 5.28%16.12B | 5.33%60.6B | 4.10%14.81B | -1.76%15.01B | 8.51%15.47B | 11.15%15.31B | 8.91%57.53B | 9.58%14.22B |
| Cost of revenue | 4.37%46.28B | 1.79%11.69B | 2.73%11.53B | 2.86%44.34B | -0.81%10.85B | -7.77%10.78B | 8.86%11.49B | 13.06%11.23B | 12.38%43.11B | 15.39%10.94B |
| Gross profit | 10.58%17.97B | 10.34%4.4B | 12.29%4.59B | 12.69%16.25B | 20.45%3.96B | 17.82%4.23B | 7.53%3.99B | 6.24%4.09B | -0.30%14.42B | -6.15%3.29B |
| Operating expense | 4.24%11.88B | 4.77%2.93B | 1.28%2.86B | 5.08%11.4B | 9.19%3.04B | 1.60%2.74B | 3.01%2.8B | 6.43%2.82B | 1.95%10.85B | 0.64%2.78B |
| Staff costs | 4.52%7.3B | ---- | ---- | 6.43%6.98B | ---- | ---- | ---- | ---- | 2.86%6.56B | ---- |
| Selling and administrative expenses | 4.86%2.18B | ---- | ---- | 5.03%2.08B | ---- | ---- | ---- | ---- | 8.75%1.98B | ---- |
| -Selling and marketing expense | 9.08%216.04M | ---- | ---- | 6.42%198.05M | ---- | ---- | ---- | ---- | 12.09%186.11M | ---- |
| -General and administrative expense | 4.41%1.97B | ---- | ---- | 4.88%1.88B | ---- | ---- | ---- | ---- | 8.42%1.79B | ---- |
| Research and development costs | -1.18%417.99M | ---- | ---- | -0.56%422.98M | ---- | ---- | ---- | ---- | 6.16%425.35M | ---- |
| Depreciation and amortization | 7.42%164.71M | ---- | ---- | 2.12%153.33M | ---- | ---- | ---- | ---- | -0.15%150.15M | ---- |
| -Depreciation | 7.42%164.71M | ---- | ---- | 2.12%153.33M | ---- | ---- | ---- | ---- | -0.15%150.15M | ---- |
| Rent and land expenses | 6.23%254.26M | ---- | ---- | 2.16%239.35M | ---- | ---- | ---- | ---- | -3.80%234.27M | ---- |
| Other operating expenses | 2.94%1.56B | ---- | ---- | 1.57%1.52B | ---- | ---- | ---- | ---- | -9.10%1.49B | ---- |
| Operating profit | 25.46%6.09B | 23.44%1.47B | 36.90%1.73B | 35.74%4.86B | 82.53%920.2M | 67.04%1.49B | 19.89%1.19B | 5.81%1.26B | -6.55%3.58B | -31.61%504.13M |
| Net non-operating interest income (expenses) | 12,029.23%31.54M | 5,768.66%3.93M | 72.31%112K | 15.56%260K | 14.04%65K | 14.55%63K | 17.54%67K | 16.07%65K | 10.84%225K | 0.00%57K |
| Non-operating interest income | 12,029.23%31.54M | 5,768.66%3.93M | 72.31%112K | 15.56%260K | 14.04%65K | 14.55%63K | 17.54%67K | 16.07%65K | 10.84%225K | 0.00%57K |
| Net investment income | 55.87%90.19M | 20.74%11.71M | 66.05%56.99M | 131.00%57.86M | 17.55%11.12M | 1.53%2.72M | -0.07%9.69M | 971.22%34.32M | 107.05%25.05M | 2,253.73%9.46M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -4.96M | 0 | 0 | -14.2M | 0 | |||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 230.86%8.5M | 124.24%1.73M | 76.03%1.29M | -169.61%-6.5M | -106.27%-269K | -89.98%180K | -326.89%-7.14M | 637.37%730K | 164.24%9.33M | 39.32%4.29M |
| Less:Other special charges | -230.86%-8.5M | -124.24%-1.73M | -76.03%-1.29M | 169.61%6.5M | 106.27%269K | 89.98%-180K | 326.89%7.14M | -637.37%-730K | -164.24%-9.33M | -39.32%-4.29M |
| Other non-operating income (expenses) | 15.07%442.61M | 14.48%113.81M | 1.46%108.94M | -19.30%384.65M | -28.95%75.64M | -9.60%102.23M | -13.58%99.41M | -24.42%107.37M | 20.80%476.64M | -6.29%106.46M |
| Income before tax | 25.85%6.66B | 23.85%1.6B | 34.93%1.89B | 29.89%5.29B | 61.24%1.01B | 60.23%1.59B | 15.31%1.29B | 4.96%1.4B | -3.88%4.08B | -26.91%624.39M |
| Income tax | 27.14%2.02B | 20.23%505.94M | 34.91%576.15M | 25.80%1.58B | 22.66%226.74M | 59.80%510.27M | 14.28%420.81M | 10.22%427.08M | -7.81%1.26B | -35.37%184.86M |
| Net income | 25.30%4.65B | 25.59%1.09B | 34.94%1.32B | 31.72%3.71B | 77.46%780.01M | 60.44%1.08B | 15.81%871.31M | 2.82%977.24M | -2.01%2.82B | -22.65%439.54M |
| Net income continuous operations | 25.30%4.65B | 25.59%1.09B | 34.94%1.32B | 31.72%3.71B | 77.46%780.01M | 60.44%1.08B | 15.81%871.31M | 2.82%977.24M | -2.01%2.82B | -22.65%439.54M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 25.30%4.65B | 25.59%1.09B | 34.94%1.32B | 31.72%3.71B | 77.46%780.01M | 60.44%1.08B | 15.81%871.31M | 2.82%977.24M | -2.01%2.82B | -22.65%439.54M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 25.30%4.65B | 25.59%1.09B | 34.94%1.32B | 31.72%3.71B | 77.46%780.01M | 60.44%1.08B | 15.81%871.31M | 2.82%977.24M | -2.01%2.82B | -22.65%439.54M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 27.75%294.43 | 29.05%69.34 | 38.61%83.57 | 32.64%230.48 | 82.33%49.43 | 61.32%67.03 | 15.75%53.73 | 2.73%60.29 | -2.08%173.77 | -22.72%27.11 |
| Diluted earnings per share | 27.75%294.43 | 29.06%69.3229 | 38.61%83.57 | 32.64%230.48 | 81.96%49.3306 | 61.32%67.03 | 15.71%53.7137 | 2.73%60.29 | -2.08%173.77 | -22.72%27.11 |
| Dividend per share | 27.78%115 | 28.57%45 | 0 | 28.57%90 | 22.22%55 | 0 | 40.00%35 | 0 | 40.00%70 | 28.57%45 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |